Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00126321
What this trial is testing

Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

Who this might be right for
Leukemia, Myelocytic, Acute
University Hospital, Bonn 50
Not applicableStudy completedNCT04242849
What this trial is testing

IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up

Who this might be right for
Acute Myeloid Leukemia
Josep Carreras Leukaemia Research Institute 354
Not applicableStudy completedNCT01507441
What this trial is testing

Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial

Who this might be right for
Leukemia
Children's Oncology Group 10
Testing effectiveness (Phase 2)Ended earlyNCT01640301
What this trial is testing

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more
Fred Hutchinson Cancer Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT07471841
What this trial is testing

Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax

Who this might be right for
IDH1 MutationRelapsed / Refractory AML
Timothy Pardee 25
Early research (Phase 1)Study completedNCT00926731
What this trial is testing

Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)

Who this might be right for
Acute Myeloid Leukemia
AstraZeneca 4
Not applicableUnknownNCT05919199
What this trial is testing

PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
First Affiliated Hospital of Jinan University 60
Early research (Phase 1)UnknownNCT05473221
What this trial is testing

Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML

Who this might be right for
AML
Zhejiang University 20
Testing effectiveness (Phase 2)Study completedNCT00629798
What this trial is testing

Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid LeukemiaAdvanced Myelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 64
Early research (Phase 1)Looking for participantsNCT06846606
What this trial is testing

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Who this might be right for
Relapsed Acute Myeloid Leukemia (AML)Refractory Acute Myeloid Leukemia (AML)Relapsed/Refractory AML+3 more
Auron Therapeutics, Inc. 69
Early research (Phase 1)Study completedNCT00006098
What this trial is testing

PS-341 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00968864
What this trial is testing

T-cell Depleted Alternative Donor Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+6 more
Wake Forest University Health Sciences 53
Not applicableStudy completedNCT01024127
What this trial is testing

Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission
Children's Oncology Group 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100
Testing effectiveness (Phase 2)Looking for participantsNCT07582172
What this trial is testing

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Complex KaryotypeMyelodysplastic Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+8 more
City of Hope Medical Center
Testing effectiveness (Phase 2)UnknownNCT05893472
What this trial is testing

A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.

Who this might be right for
Acute Myeloid LeukemiaVenetoclax
ZePing Zhou 45
Large-scale testing (Phase 3)UnknownNCT01828489
What this trial is testing

Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years

Who this might be right for
Pediatric Acute Myeloblastic Leukemia
Vastra Gotaland Region 300
Not applicableApproved For MarketingNCT03070093
What this trial is testing

Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)

Who this might be right for
Acute Myeloid Leukemia (AML)FMS-like Tyrosine Kinase-3 (FLT3) Mutations
Astellas Pharma Global Development, Inc.
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Not applicableUnknownNCT05000801
What this trial is testing

Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Affiliated Hospital to Academy of Military Medical Sciences 20
Next Page
35